NURAF Nomura Research Institute Ltd. Forecast, Technical & Fundamental Analysis

NURAF in upward trend: price may jump up because it broke its lower Bollinger Band on November 04, 2025

NURAF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 17 cases where NURAF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 03, 2025. You may want to consider a long position or call options on NURAF as a result. In of 63 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NURAF just turned positive on November 06, 2025. Looking at past instances where NURAF's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

NURAF moved above its 50-day moving average on November 07, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for NURAF crossed bullishly above the 50-day moving average on November 17, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NURAF advanced for three days, in of 122 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 33 cases where NURAF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.496) is normal, around the industry mean (9.949). P/E Ratio (35.130) is within average values for comparable stocks, (48.853). NURAF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.453). Dividend Yield (0.012) settles around the average of (0.025) among similar stocks. P/S Ratio (4.550) is also within normal values, averaging (49.513).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NURAF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NURAF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.